<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02987361</url>
  </required_header>
  <id_info>
    <org_study_id>CBNUH_MDCTC_2015_tDCS</org_study_id>
    <nct_id>NCT02987361</nct_id>
  </id_info>
  <brief_title>Effect of tDCS on Upper Extremity After Strokes</brief_title>
  <official_title>Effects of Transcranial Direct Current Stimulation on Hemiplegic Upper Extremity Function After Strokes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Yangsan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve
      upper limb motor recovery in the sub-acute phase of stroke patients.

      This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve
      upper limb motor recovery in the sub-acute phase of stroke patients.

      This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial.

      Informed consent was obtained from all participants and procedures were conducted according
      to the Declaration of Helsinki. The protocol was approved by the Chonbuk National Uni.
      Hospital IRB, KOREA.

      Seventy-two stroke patients in the sub-acute phase will be recruited in three centers of
      neurorehabilitation in republic of Korea.

      Patients will be randomly divided to four groups; group1 is anodal stimulation on the
      lesioned primary motor cortex, group 2 is cathodal stimulation on the non-lesioned primary
      motor cortex, group 3 is dual stimulation such as anodal stimulation on the lesioned side and
      cathod stimulation on the non-lesioned side, and group 4 is shame stimulation group.

      The stimulation will be conducted 2mA for 20 minute a day, 5 days per weeks, totally 2 weeks.

      Fugl-Meyer upper motor score will be measured as a primary outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Upper Motor Score change</measure>
    <time_frame>before treatment, 48 hours after treatment, 4 weeks after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Manual Muscle Test (MMT) change</measure>
    <time_frame>before treatment, 48 hours after treatment, 4 weeks after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion (ROM) change</measure>
    <time_frame>before treatment, 48 hours after treatment, 4 weeks after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Korean version Modified Bathel Index (KMBI) change</measure>
    <time_frame>before treatment, 48 hours after treatment, 4 weeks after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>treatment group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>anodal stimulation on the lesioned primary motor cortex DC-STIMULATOR PLUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treatment group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cathodal stimulation on the non-lesioned primary motor cortex DC-STIMULATOR PLUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treatment group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dual stimulation such as anodal stimulation on the lesioned side and cathodal stimulation on the non-lesioned side DC-STIMULATOR PLUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC-STIMULATOR PLUS</intervention_name>
    <description>2mA for 20minutes a day, 5 days per weeks, totally 2 weeks</description>
    <arm_group_label>treatment group 1</arm_group_label>
    <arm_group_label>treatment group 2</arm_group_label>
    <arm_group_label>treatment group 3</arm_group_label>
    <arm_group_label>sham group</arm_group_label>
    <other_name>tDCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 20-85

          2. Unilateral Stroke patients

          3. Inclusion must be in the sub-acute phase defined as within 48hr-4 weeks after stroke

          4. Patients who have evoked motor potentials on the first dorsal interossei muscles on
             hemiplegic hand

          5. The patient has subscribed the informed consent

        Exclusion Criteria:

          1. Insert a metal object on the head

          2. Convulsive disorders

          3. History of brain diseases other than stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myoung Hwan Ko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>634-18, Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk, 561-712 Republic of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Min Jung YU, MANAGER</last_name>
    <phone>82-63-259-3458</phone>
    <phone_ext>3458</phone_ext>
    <email>mjyu@mdctc.or.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myoung Hwan Ko, MD, PhD</last_name>
    <phone>82-63-250-1795</phone>
    <phone_ext>1795</phone_ext>
    <email>mhko@jbnu.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kim Yeon Hee</name>
      <address>
        <city>Seoul City</city>
        <state>Ilwon</state>
        <zip>06355</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AH HE LEE, MS</last_name>
      <phone>82-2-6007-5408</phone>
      <email>ahee.lee@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2016</study_first_submitted>
  <study_first_submitted_qc>December 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2016</study_first_posted>
  <last_update_submitted>December 7, 2016</last_update_submitted>
  <last_update_submitted_qc>December 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonbuk National University Hospital</investigator_affiliation>
    <investigator_full_name>Myoung Hwan Ko</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

